Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Financial toxicity associated with treatment of localized prostate cancer
Brandon S. Imber, Melissa Varghese, Behfar Ehdaie, et al.
Nature Reviews Urology (2019) Vol. 17, Iss. 1, pp. 28-40
Open Access | Times Cited: 57

Showing 1-25 of 57 citing articles:

Quantifying Suicide Risk in Prostate Cancer: A SEER-Based Predictive Model
Jiaxiang Du, Fen Zhang, Weinan Zheng, et al.
Journal of Epidemiology and Global Health (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Intermediate clinical endpoints for surrogacy in localised prostate cancer: an aggregate meta-analysis
Laila A. Gharzai, Ralph Jiang, David G. Wallington, et al.
The Lancet Oncology (2021) Vol. 22, Iss. 3, pp. 402-410
Open Access | Times Cited: 98
Financial toxicity following surgical treatment for colorectal cancer: a cross-sectional study
Minghui Mo, Peipei Jia, Kai Zhu, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 2
Open Access | Times Cited: 29
A Systematic Review of New Imaging Technologies for Robotic Prostatectomy: From Molecular Imaging to Augmented Reality
Severin Rodler, Marc Kidess, Thilo Westhofen, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 16, pp. 5425-5425
Open Access | Times Cited: 18
A Theoretical Model of Financial Burden After Cancer Diagnosis
Salene M. W. Jones, Nora B. Henrikson, Laura Panattoni, et al.
Future Oncology (2020) Vol. 16, Iss. 36, pp. 3095-3105
Open Access | Times Cited: 37
Subjective and objective financial toxicity among colorectal cancer patients: a systematic review
Meram Azzani, Zahir Izuan Azhar, Aimi Nadira Mat Ruzlin, et al.
BMC Cancer (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 4
Associations of financial toxicity with symptoms and unplanned healthcare utilization among cancer patients taking oral chemotherapy at home: a prospective observational study
Yongfeng Chen, Zhenxiang Chen, Haiyun Jin, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 10
Medicaid Expansion and Survival Outcomes Among Men With Prostate Cancer
Oluwasegun Akinyemi, Mojisola E Fasokun, Eric Hercules, et al.
Cureus (2025)
Open Access
Perceived barriers and facilitators affecting utilisation of radiation therapy services: Scoping review findings − Patient and department level influences
Leah Cramp, Tracy Burrows, Yolanda Surjan
Radiotherapy and Oncology (2025) Vol. 204, pp. 110725-110725
Open Access
Aspartoacylase suppresses prostate cancer progression by blocking LYN activation
Hong Weng, Kangping Xiong, Wang Wang, et al.
Military Medical Research (2023) Vol. 10, Iss. 1
Open Access | Times Cited: 7
Real-world Evidence to Estimate Prostate Cancer Costs for First-line Treatment or Active Surveillance
Christopher J. Magnani, Nicolas Bievre, Laurence C. Baker, et al.
European Urology Open Science (2020) Vol. 23, pp. 20-29
Open Access | Times Cited: 19
Out-of-Pocket Costs and Provider Payments in Cleft Lip and Palate Repair
Danielle H. Rochlin, L Ma, Clifford C. Sheckter, et al.
Annals of Plastic Surgery (2022) Vol. 88, Iss. 4, pp. S343-S347
Open Access | Times Cited: 12
A randomized phase II trial of MR-guided prostate stereotactic body radiotherapy administered in 5 or 2 fractions for localized prostate cancer (FORT)
Sydney Wolfe, Marshall A. Diven, Ariel E. Marciscano, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Patient-Reported Financial Toxicity Associated With Management of Nephrolithiasis
Shaan Setia, David G. Gelikman, Jackson Cabo, et al.
Urology (2023) Vol. 174, pp. 52-57
Closed Access | Times Cited: 6
Assessment of the prevalence and related factors of financial toxicity in cancer patients based on the COST scale: A systematic review and meta-analysis
Shuping Wang, Jialin Wang, Hua Kang, et al.
European Journal of Oncology Nursing (2023) Vol. 68, pp. 102489-102489
Closed Access | Times Cited: 6
Hypofractionated Postprostatectomy Radiation Therapy for Prostate Cancer to Reduce Toxicity and Improve Patient Convenience: A Phase 1/2 Trial
Nolan A. Wages, Jason C. Sanders, A Smith, et al.
International Journal of Radiation Oncology*Biology*Physics (2020) Vol. 109, Iss. 5, pp. 1254-1262
Open Access | Times Cited: 15
The Effects of Multimodal Prehabilitation Interventions in Men Affected by Prostate Cancer on Physical, Clinical and Patient Reported Outcome Measures: A Systematic Review
Catherine Paterson, Cara Roberts, Maria Kozlovskaia, et al.
Seminars in Oncology Nursing (2022) Vol. 38, Iss. 5, pp. 151333-151333
Open Access | Times Cited: 9
The costs and inequities of precision medicine for patients with prostate cancer: A call to action
Meera Ragavan, Hala T. Borno
Urologic Oncology Seminars and Original Investigations (2023) Vol. 41, Iss. 9, pp. 369-375
Closed Access | Times Cited: 4
Editorial Comment: Physician Perspectives on the Nonclinical Factors That Contribute to Decision-Making for Advanced Prostate Cancer Care: A Qualitative Study
Sydney Strup, Andrew Harris
JU Open Plus (2024) Vol. 2, Iss. 3
Open Access | Times Cited: 1
An optimized prostate biopsy strategy in patients with a unilateral lesion on prostate magnetic resonance imaging avoids unnecessary biopsies
Auke Jager, Luigi A.M.J.G. van Riel, Arnoud W. Postema, et al.
Therapeutic Advances in Urology (2022) Vol. 14
Open Access | Times Cited: 7
The impact of management option on out-of-pocket costs and perceived financial burden among men with localised prostate cancer in Australia within 6 months of diagnosis
Daniel Lindsay, Penelope Schofield, Dorean Nabukalu, et al.
Australian Health Review (2024) Vol. 48, Iss. 2, pp. 172-181
Open Access | Times Cited: 1
WDR1 promotes prostate cancer progression through Wnt/β-catenin signaling
Jinfeng Cheng, Dan Huo, Zhonghua Zhang, et al.
Medical Oncology (2024) Vol. 41, Iss. 6
Closed Access | Times Cited: 1
Patient-Reported Financial Burden Following Stereotactic Body Radiation Therapy for Localized Prostate Cancer
Tamir Sholklapper, Michael Creswell, Alexandra T. Payne, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 6
The “Natural History” of Evidence on Radical Prostatectomy: What Have 20 Years of Robots Given Us?
Tomás Bernardo Costa Moretti, Leonardo Oliveira Reis
European Urology Focus (2022) Vol. 8, Iss. 6, pp. 1859-1860
Closed Access | Times Cited: 6
New technology in prostate cancer and financial toxicity
Avinash Maganty, Brent K. Hollenbeck
Urologic Oncology Seminars and Original Investigations (2023) Vol. 41, Iss. 9, pp. 376-379
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top